Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic ResponsesJonathan B. Mitchem, David G. DeNardo, Brett L. Knolhoff et al.|Cancer Research|2012Cited by 941
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progressionDavid G. DeNardo, Lisa M. Coussens|Breast Cancer Research|2007Cited by 679
Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic CancerJad I. Belle, David G. DeNardo|Cancer Discovery|2024Cited by 95
Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunityXiuting Liu, David G. DeNardo|Cancer Cell|2023Cited by 89
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, David G. DeNardo|The Journal of Experimental Medicine|2023Cited by 43